Close
Back to KDMN Stock Lookup

Kadmon (KDMN) – Hot FDA News

Jul 16, 2021 02:22 PM Kadmon (KDMN) Announces U.S. FDA Grants Full Approval of REZUROCK (belumosudil) for the Treatment of Patients with Chronic Graft-Versus-Host Disease
Mar 10, 2021 04:16 PM Kadmon (KDMN) Announces U.S. FDA Has Extended the Review Period for Belumosudil in Chronic Graft-Versus-Host Disease
Nov 11, 2019 04:26 PM
Sep 17, 2019 04:42 PM
Dec 11, 2017 05:51 AM
Jul 11, 2017 08:03 AM

Back to KDMN Stock Lookup